Macrolides, lincosamides and streptogramins systemic use: consumption in Europe 2022
This statistic displays the community consumption of macrolides, lincosamides, and streptogramins (J01F) for systemic use in Europe in 2022, by country. The defined daily dose (DDD) of macrolides, lincosamides, and streptogramins per 1,000 inhabitants per day in the community (primary care) sector in Greece amounted to 7.2 in that year.